Actively Recruiting
Characterization of (A)Typical Sensorimotor Pathways in Individuals With Autism
Led by IRCCS Eugenio Medea · Updated on 2026-02-05
300
Participants Needed
1
Research Sites
132 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The goal of this interventional study is to understand whether sensorimotor skills could represent an endophenotype for autism, i.e. a specific class of biomarkers that bridges the gap between biological components of a condition and the behavioral/clinical dimensions. Motor and sensory differences are often observed in people with autism and may appear early in development or be shared among family members. The study will address three main questions: * What are the developmental effects of early differences in motor and sensory skills? * Are motor and sensory abilities influenced by family relationships? * Can studying motor and sensory differences in autism help researchers better understand the biological mechanisms underlying the condition? This study is structured in three topic-oriented work packages (WPs): WP1, a longitudinal assessment of sensorimotor skills as early predictors of later social characteristics in a mixed sample of infant siblings of autistic children (at elevated likelihood of autism) or with typical familial likelihood (no first-degree relatives with autism) (Q1); WP2, a cross-sectional investigation of sensorimotor abilities in autistic children and their parents as compared with typically developing children and their parents (Q2); and WP3, a dense-phenotyping approach to establish, within individuals, associations between traits across behavioral, neural, and molecular levels.
CONDITIONS
Official Title
Characterization of (A)Typical Sensorimotor Pathways in Individuals With Autism
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Children aged 2 to 12 years (both autistic and typically developing)
- Clinical diagnosis of Autism Spectrum Disorder based on DSM-5 criteria (for the autism group)
- Being parents of enrolled children (both autistic and typically developing)
- Infants younger than 24 months with a first-degree family member diagnosed with Autism Spectrum Disorder
You will not qualify if you...
- Presence of medical or neurological conditions of clinical significance, including epilepsy
- Presence of dysmorphic syndromes or known genetic syndromes
- Current use of medications and/or psychotropic drugs
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
IRCCS E. Medea
Bosisio Parini, Lecco, Italy, 23842
Actively Recruiting
Research Team
A
Alessandro Crippa, PhD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
DIAGNOSTIC
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here